Overall, the gut microbiota functions as a dynamic regulator of brain plasticity and cognitive resilience across the lifespan, suggesting shared systems-level vulnerabilities across conditions and highlighting the translational potential of microbiota-targeted interventions such as probiotics, dietary modulation, postbiotics, and precision microbiome-based strategies.
Abstract
The gut microbiota has emerged as a key regulator of central nervous system development and function. Accumulating experimental and clinical evidence demonstrates that microbial signals influence brain activity through integrated neural, immune, neuroendocrine, and metabolic pathways. These pathways converge on core mechanisms of synaptic plasticity, including neurotrophic signaling, glutamatergic transmission, dendritic remodeling, and adult neurogenesis, thereby shaping learning, memory, executive function, and emotional regulation. Disruption of microbiota-brain communication is implicated in a range of neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder (ASD), major depressive disorder (MDD), Alzheimer's disease (AD), and Parkinson's disease (PD), suggesting shared systems-level vulnerabilities across conditions and highlighting the translational potential of microbiota-targeted interventions such as probiotics, dietary modulation, postbiotics, and precision microbiome-based strategies. Overall, the gut microbiota functions as a dynamic regulator of brain plasticity and cognitive resilience across the lifespan. Future progress will require identification of causal mechanisms at the level of specific microbial metabolites, neural circuits, and developmental windows using integrated multi-omics and spatially resolved approaches, alongside translation into targeted therapeutic strategies.
This review summarizes evidence across seven major neuropsychiatric disorders, Depression, Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, Alzheimer's disease, Schizophrenia, Anxiety and Obsessive Compulsive Disorder, demonstrating that dysregulation of the MGBA constitutes a shared pathological mec...
Tong-Yun Li, Yiheng Chang, Shi-Qi Tang et al.· Brain Research Bulletin· 0 citations
This chapter summarizes current knowledge of the microbiota-gut-brain axis (MGBA) and elucidates how intestinal microbes and their metabolites communicate with the central nervous system via neural, immune, endocrine, and metabolic pathways.
Gopal Khodve, Shaswat Raval, Sugato Banerjee· International review of neur...· 0 citations
Accumulating data associate ASD-related microbial profiles with changes in brain structure, functional connectivity, and transcriptomic patterns, supporting a mechanistic role for the MGB axis in ASD phenotypes.
Increasing evidence supports a role for microbiota-dependent pathways in modulating seizure activity and treatment responsiveness, and suggests that while some microbial metabolites may directly influence neuronal hyperexcitability and seizure susceptibility, others likely exert secondary or modulatory effects through...
Allison Gallucci, Xi Guo, D. Shukla et al.· Cells· 0 citations
The gut–brain axis represents a potentially modifiable interface linking microbial dysbiosis and neuroinflammation and further integration of microbiomics, metabolomics, immunophenotyping, and longitudinal clinical data is needed to establish causality and advance precision strategies for neurodegenerative diseases.
This review summarizes current evidence on alterations in the gut microbiota in ASD and critically examines whether these changes contribute to disease pathogenesis or represent secondary effects, and highlights recent advances in multi-kingdom microbiome profiling, metabolomics, mechanistic studies of neuro inflammati...
Ahmed Kabrah, Saad Alghamdi, Anmar A. Khan et al.· Journal of Disability Resear...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.